Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department

Internal and Emergency Medicine

Volumn 6, Issue 6, 2011, Pages 547-555

  Lin, Jiun Nong ^a,b   Chen, Yen Hsu ^b,c   Chang, Lin Li ^b,d   Lai, Chung Hsu ^a,b   Lin, Hsing Lin ^b,c   Lin, Hsi Hsun ^a  

^a E DA HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bacteremia; Emergency department; ESBL; Extended spectrum lactamase; Risk factors

Indexed keywords

BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; KLEBSIELLA INFECTION; MALE; MEDICAL AUDIT; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROTEUS INFECTION; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; EMERGENCY SERVICE, HOSPITAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROTEUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 81955164173     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0707-3     Document Type: Article

References (30)

1. McCaig LF, McDonald LC, Cohen AL et al (2007) Increasing blood culture use at US hospital emergency department visits, 2001 to 2004. Ann Emerg Med 50: 42-48.
2. Javaloyas M, Garcia-Somoza D, Gudiol F (2002) Epidemiology and prognosis of bacteremia: a 10-yr study in a community hospital. Scand J Infect Dis 34: 436-441.
3. Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48: 1-12.
4. Livermore DM (2003) Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36(Suppl 1): S11-S23.
5. Pitout JDD, Nordmann P, Laupland KB et al (2005) Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
6. Falagas ME, Karageorgopoulos DE (2009) Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 73: 345-354.
7. Rodríguez-Baño J, Picón E, Gijón P et al (2010) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50: 40-48.
8. Rodríguez-Baño J, Alcalá JC, Cisneros JM et al (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168: 1897-1902.
9. Rodríguez-Baño J, Navarro MD, Ngugro MD (2008) Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective. Clin Microbiol Infect 14(Suppl 1): 104-110.
10. Pitout JDD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159-166.
11. Cuevas O, Cercenado E, Gimeno M et al (2010) Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study. Diagn Microbiol Infect Dis 67: 251-260.
12. Lin JN, Tsai YS, Lai CH et al (2009) Risk factors for mortality of bacteremic patients in the emergency department. Acad Emerg Med 16: 749-755.
13. Burgess DS, Hall RG, Lewis JS et al (2003) Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period. Pharmacotherapy 23: 1232-1237.
14. Lee CH, Su LH, Tang YF et al (2006) Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. J Antimicrob Chemother 58: 1074-1077.
15. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
16. Musikatavorn K, Chumpengpan C, Sujinpram C (2011) Risk factors of extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia in Thai emergency department: a retrospective case-control study. Asian Biomed 5: 129-138.
17. Weinstein MP (2003) Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 41: 2275-2278.
18. Clinical and Laboratory Standards Institute (2005-2009) Performance Standards for Antimicrobial Susceptibility Testing, 15th-19th informational supplements, document M100-S15-19. Wayne, PA.
19. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530-538.
20. Kaye KS, Friedman ND, Stout JE et al (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137: 791-797.
21. Kang CI, Cheong HS, Chung DR et al (2008) Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 27: 85-88.
22. Ortega M, Marco F, Soriano A et al (2009) Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 63: 568-574.
23. Lautenbach E, Patel JB, Bilker WB et al (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32: 1162-1171.
24. Kuster SP, Hasse B, Huebner V et al (2010) Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 38: 33-40.
25. Tumbarello M, Spanu T, Sanguinetti M et al (2006) Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50: 498-504.
26. Kang C, Kim S, Kim DM et al (2004) Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25: 860-867.
27. Pitout JDD, Church DL, Hanson ND et al (2004) Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis 38: 1736-1741.
28. Kumar A, Ellis P, Arabi Y et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136: 1237-1248.
29. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589-1596.
30. Tumbarello M, Sanguinetti M, Montuori E et al (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51: 1987-1994.